A TECHNO-ECONOMIC NEWS MAGAZINE FOR MEDICAL PLASTICS AND PHARMACEUTICAL INDUSTRY
Our 21st Year of Publication
Page  7 of 12

Cover Story

Invited Speakers & Panel Experts : Presentation Abstracts

Mr. Sarabjot Singh
Sterimed Surgicals
India Pvt. Ltd.,
New Delhi
Dr. Hemant Desai
Former DGM (Operation),
Nirma Ltd. - Healthcare
Division, Ahmedabad
Dr. Pradeep Patel
Head (Research &
Development), Polymer
Tech. International (Care
Group), Vadodara
Mr. Sunil Khokarale
Sr. Manager, Tata Consultancy
Services, Pune

“Career Planning In Biomedical Engineering”

Mr. Ravi Shankar Shrivastava
Chairman & MD,
Invent Bio-Med Pvt. Ltd., Mumbai

“Market Potential For Cardiovascular Devices in India”

Dr. C. S. Bhaskaran Nair
Terumo Penpol Limited, Trivandrum

“Developments In Transfusion Technology”

Dr. Tarang Patel
Oncology Sergeon
Shrey Hospital, Ahmedabad
       
Dr. Renuka Mishra
Assistant Professor,
Institute of Pharmacy,
Nirma University, Ahmedabad

“Innovations In Medical Devices”

As per Center for devices and radiological health (CDRH), US FDA, Medical device does not achieve its principle intended by chemical action or being metabolized. These devices vary from simple tongue presser and thermometer to complex one such as device used for robotic surgery.The medical devices are classified on risk basis for the regulatory control namely Class I, II and III. Innovations in medical devices inlcudes diagnostic devices that can be used for high throughput gene sequencing, often referred to as “next generation sequencing". These instruments allow sequencing a patient’s DNA and provide physicians to look at the patients’ genetic makeup and help in diagnosing disease or identifying the cause of symptoms. US FDA has also approved Cerena Transcranial Magnetic Stimulator (TMS), the first device to relieve pain caused by migraine headaches. A pulse of magnetic energy is used to stimulate occipital cortex of the brain. Another innovation is RNS system, developed by NeuroPace, Inc helps to reduce the frequency of seizures in epilepsy patients and have not responded well to medications. It consists of a stimulator implanted in the skull under the scalp and leads implanted in the brain. Other innovations which will change the scenario of medical devices include 1) A handheld tool for multispectral analysis of tissue morphology to identify whether there is a need for biopsy for moles causing cancer. 2) A technology for blocking sphenopalatine ganglion (SPG) signals at the first sign of a headache. The system involves the permanent implant of a small nerve stimulating device in the upper gum on the side of the head normally affected by headache. 3) Replacement of the needle used for blood glucose testing with a patch is another major requirement. The technology utilizes transdermal biosensor that reads blood analytes through the skin without drawing blood. 4) Transcatheter aortic valve is a life-saving alternative to open-heart surgery for patients. The valve is guided through the femoral artery by catheter from a small incision near the rib cage. Thus, it can concluded that innovations in medical devices will be the need of the hour as per patient's requirements.

Page  1  :  2  :  3  :  4  :  5  :  6  :  7  :  8  :  9  :  10  :  11  :  12

Back | Back to Top | Previous | Next